Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
18F-rhPSMA-7.3
PET/CT
Locations
2
United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
June 30, 2024
Primary Completion Date
June 30, 2026
Completion Date
June 20, 2027
Last Updated
November 5, 2025
NCT05939414
NCT07005154
NCT05751941
NCT06835218
NCT07181161
NCT07190300
Lead Sponsor
Brigham and Women's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions